GAS5 overexpression has also been demonstrated to repress endometrial cancer formation in immunodeficient mice models through PTEN/AKT signaling and directly repressing oncogenic yes-associated protein 1 (YAP1) in tumor-associated macrophages, transforming them into an anti-tumor phenotype [44]. The gene discussed is GAS5; the disease is endometrial cancer.